The size of the global protein a resins market is expected to be worth USD 729.1 million by 2026 from USD 492.6 million in 2021, growing at a CAGR of 8.2% from 2021 to 2026. The market is showcasing the evident potential in the mentioned forecasting period. Increasing research on monoclonal antibodies is expected to drive sales of Protein A resins over the forecast period.
MARKET DRIVERS:
The growing demand for the best treatment of chronic diseases to get better results that are cost-effective and widely accepted. Protein A resins are commonly used in chromatography as well. The increasing use of chromatography in drug discovery and protein engineering has given rise to a wide range of protein-based drugs that accelerate the global protein A resins market.
The global protein A resins market is further expected to grow at a steady growth rate during the forecast period, owing to factors such as increasing applications of monoclonal antibody diagnostics and therapies to manage chronic diseases such as cancer, rheumatoid arthritis, etc., increasing research interest in synthetic biology to the adoption of protein products to make protein-infused drugs and formulations, collaboration and acquisitions of major market players, growing technological developments, demand for prepackaged disposable columns, the increased demand for therapeutic antibodies and the increase in pharmaceutical R&D spending. In Europe, key pharmaceutical and biopharmaceutical research centers have been established over the past several years. Additionally, regulatory agencies' increased approvals of monoclonal antibody products to meet the growing demand for immunotherapy are estimated to further fuel the protein A resins market growth.
Many significant advances have been observed in monoclonal antibodies, which are used to treat a large number of chronic and infectious diseases. Protein A resins are widely used to purify monoclonal antibodies, a critical factor that improves growth prospects for the next forecast period. In addition, massive clinical trials in synthetic biologics and monoclonal antibodies are expected to increase the global A resins market uptake.
MARKET RESTRAINTS:
However, the high cost associated with these high-end products may restrain the market's growth during the forecast period. Additionally, the availability of alternatives such as crystallization, ultrafiltration, and others as purification methods could slow the development of the market during the forecast period.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2020 to 2026 |
|
Base Year |
2020 |
|
Forecast Period |
2021 to 2026 |
|
Segments Covered |
By Product Type, Application, End-User, Matrix Type, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
GE Healthcare, Repligen Corporation, Novasep, Tosoh Bioscience, GenScript, Thermo Fisher Scientific, EMD Millipore, and Expedeon Ltd. |
This research report on the global protein a resins market has been segmented & sub-segmented based on the product type, application, end-user, matrix type, and region.
Protein A Resins Market - By Product Type:
Based on product type, the segment of Recombinant Protein A accounts for the largest share of the market during the forecast period. Recombinant protein A is produced in E. coli and functions the same way as normal protein A resins. Nonetheless, the recombinant protein type is favored where another production origin provides less non-specific binding.
Protein A Resins Market - By Application:
Based on the application, the segment of immunoprecipitation is expected to show the highest growth during the forecast period. In the research and development sector, immunoprecipitation is widely applicable. As protein A resins are used in immunoprecipitation techniques, it is predicted that their demand will go hand in hand with increasing demand for immunoprecipitation. In addition, the growing demand for therapeutic antibodies and high antibody research and development activities will also contribute to improving the growth of the segment to some extent.
Protein A Resins Market - By Matrix Type:
Based on the matrix type, The Glass or Silica based matrix segment is expected to show significant growth over the forecast period owing to improved longevity, mechanical strength, and ability to integrate high metal dopant absorption.
Protein A Resins Market - By End User:
Based on End User, Biopharmaceutical companies extensively use protein A resins to purify monoclonal antibodies with great alarm. The biopharmaceutical industry's development of therapeutic monoclonal antibodies is expected to rise to meet its growing demand. As monoclonal antibodies' production increases, the need for protein A resins for large-need purification will increase. In addition, the ever-increasing trend of outsourcing large-scale production to contract research organizations would also increase the clinical research laboratories' end-user segment in the market.
Protein A Resins Market - By Region:
Geographically, the North American region was the largest market for Protein A resin, accounting for approximately 37% in 2020 due to many investments in the development of monoclonal antibodies, followed by Europe. The European protein A resin market was dominated by the German protein A resin market in 2020 and is expected to show a positive trend throughout the projection period. The majority of the sales revenues would be due to drug discovery and development and the growing demand for immunotherapy drugs to treat chronic diseases. As a result, the uptake of protein A resins products is increasing at a reasonable rate. In addition, increased investment in protein research is attracting market players to establish their businesses in Germany.
The UK Protein A resins market is expected to grow at over 7.4% CAGR during the forecast period. However, the increase in the adoption by various industries and the presence of the major market players in the country will influence the market's growth in the future. In addition, the region has a high demand for recombinant proteins, immunoglobulins, and protein antigen complexes which have led to an expansion of immunotherapy applications in the UK.
Other European countries such as Sweden, Switzerland, Netherland, and France are expected to have a healthy market rate during the projected period. The presence of the major market players in these countries has significantly impacted the growth of the European protein A resins market. In addition, the increasing rate of chronic diseases such as rheumatoid arthritis will generate significant market growth. For example, in Sweden, the overall nationwide incidence of rheumatoid arthritis was around 42 per 100,000, with a high rate of incidences occurring in the age group of 70–79 years for both women and men.
Asia Pacific region is estimated to be the fastest-growing region with a healthy compound annual growth rate due to many untapped markets and growing awareness about the developments in the market.
KEY MARKET PLAYERS:
Companies leading the global protein A resins market profiled in the report are GE Healthcare, Repligen Corporation, Novasep, Tosoh Bioscience, GenScript, Thermo Fisher Scientific, EMD Millipore, and Expedeon Ltd. Major Players in the market enter into strategic agreements to develop raw materials required to manufacture Protein A resins.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 Natural Protein A Resin
5.1.2 Recombinant Protein A Resin
5.2 By Application
5.2.1 Immunoprecipitation
5.2.2 Antibody Purification
5.3 By End Users
5.3.1 Biopharmaceutical Manufacturers
5.3.2 Clinical Research Laboratories
5.3.3 Academic Institutes
5.4 By Matrix Type
5.4.1 Glass or Silica
5.4.2 Agarose
5.4.3 Organic Polymer
6. Geographical Analysis
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Mexico
6.4.4 Rest of Latin America
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Thermo Fisher Scientific
8.3 Repligen
8.4 Tosoh Bioscience
8.5 EMD Millipore
8.6 Novasep
8.7 GenScript
8.8 Expedeon Ltd
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
